<h3>提升您的投资策略：</h3>
<ul>
<li>享受 TipRanks Premium 50% 的折扣！解锁强大的投资工具、高级数据和专家分析师见解，帮助您自信投资。</li>
</ul>
<p>Healius Limited ( (AU:HLS) ) 提供了最新动态。</p>
<p>Healius Limited 宣布董事的持股变动，董事 John Mattick 通过市场交易购买了 200,000 股普通股。这一收购反映了 Mattick 持股的显著增加，可能表明对公司未来表现和稳定性的信心，这可能对利益相关者的看法产生积极影响。</p>
<p>关于 (AU:HLS) 股票的最新分析师评级为持有，目标价格为 0.87 澳元。要查看 Healius Limited 股票的完整分析师预测列表，请访问 AU:HLS 股票预测页面。</p>
<p><strong>关于 Healius Limited 的更多信息</strong></p>
<p>Healius Limited 在医疗行业内运营，提供医疗和诊断服务。该公司以其广泛的病理实验室和诊断影像中心网络而闻名，专注于在澳大利亚提供可及的医疗解决方案。</p>
<p><strong>平均交易量：</strong> 6,548,766</p>
<p><strong>技术情绪信号：</strong> 卖出</p>
<p><strong>当前市值：</strong> 6.245 亿澳元</p>
<p>要全面评估 HLS 股票，请访问 TipRanks 的股票分析页面。</p>
<h2>热门文章：</h2>
<ul>
<li>CAPR 诉讼警报！针对 Capricor Therapeutics 的集体诉讼</li>
<li>META 还是 GOOGL：顶级分析师选择的 ‘顶级消费 AI 投资’</li>
<li>特斯拉在中国将新款 Model 3 价格下调 4%，而挪威销量激增 38%</li>
</ul>
<p>免责声明与披露报告问题</p>

<p>Healius Limited 的董事 John Mattick 通过收购 200,000 股普通股增加了他的持股，显示出对公司未来表现的信心。目前，Healius（AU:HLS）的分析师评级为持有，目标价格为 0.87 澳元。Healius 在医疗保健行业运营，提供遍布澳大利亚的医疗和诊断服务，市值为 6.245 亿澳元</p>

<h3>Elevate Your Investing Strategy:</h3>
<div class="lb-trans"><h3>提升您的投资策略：</h3>
</div><ul>
<li>Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.</li>
</ul>
<div class="lb-trans"><ul>
<li>享受 TipRanks Premium 50% 的折扣！解锁强大的投资工具、高级数据和专家分析师见解，帮助您自信投资。</li>
</ul>
</div><p>Healius Limited ( (AU:HLS) ) has provided an update.</p>
<div class="lb-trans"><p>Healius Limited ( (AU:HLS) ) 提供了最新动态。</p>
</div><p>Healius Limited announced a change in the director’s interest, with Director John Mattick acquiring 200,000 ordinary shares through on-market trades. This acquisition reflects a significant increase in Mattick’s holdings, potentially indicating confidence in the company’s future performance and stability, which could positively influence stakeholder perceptions.</p>
<div class="lb-trans"><p>Healius Limited 宣布董事的持股变动，董事 John Mattick 通过市场交易购买了 200,000 股普通股。这一收购反映了 Mattick 持股的显著增加，可能表明对公司未来表现和稳定性的信心，这可能对利益相关者的看法产生积极影响。</p>
</div><p>The most recent analyst rating on (AU:HLS) stock is a Hold with a A$0.87 price target. To see the full list of analyst forecasts on Healius Limited stock, see the AU:HLS Stock Forecast page.</p>
<div class="lb-trans"><p>关于 (AU:HLS) 股票的最新分析师评级为持有，目标价格为 0.87 澳元。要查看 Healius Limited 股票的完整分析师预测列表，请访问 AU:HLS 股票预测页面。</p>
</div><p><strong>More about Healius Limited</strong></p>
<div class="lb-trans"><p><strong>关于 Healius Limited 的更多信息</strong></p>
</div><p>Healius Limited operates within the healthcare industry, providing medical and diagnostic services. The company is known for its extensive network of pathology laboratories and diagnostic imaging centers, focusing on delivering accessible healthcare solutions across Australia.</p>
<div class="lb-trans"><p>Healius Limited 在医疗行业内运营，提供医疗和诊断服务。该公司以其广泛的病理实验室和诊断影像中心网络而闻名，专注于在澳大利亚提供可及的医疗解决方案。</p>
</div><p><strong>Average Trading Volume:</strong> 6,548,766</p>
<div class="lb-trans"><p><strong>平均交易量：</strong> 6,548,766</p>
</div><p><strong>Technical Sentiment Signal:</strong> Sell</p>
<div class="lb-trans"><p><strong>技术情绪信号：</strong> 卖出</p>
</div><p><strong>Current Market Cap:</strong> A$624.5M</p>
<div class="lb-trans"><p><strong>当前市值：</strong> 6.245 亿澳元</p>
</div><p>For a thorough assessment of HLS stock, go to TipRanks’ Stock Analysis page.</p>
<div class="lb-trans"><p>要全面评估 HLS 股票，请访问 TipRanks 的股票分析页面。</p>
</div><h2>Trending Articles:</h2>
<div class="lb-trans"><h2>热门文章：</h2>
</div><ul>
<li>CAPR Lawsuit Alert! Class Action Lawsuit Against Capricor Therapeutics</li>
<li>META or GOOGL: Top Analyst Picks the ‘Top Consumer AI Play’</li>
<li>Tesla Cuts New Model 3 Prices by 4% in China, While Norway Sales Surge 38%</li>
</ul>
<div class="lb-trans"><ul>
<li>CAPR 诉讼警报！针对 Capricor Therapeutics 的集体诉讼</li>
<li>META 还是 GOOGL：顶级分析师选择的 ‘顶级消费 AI 投资’</li>
<li>特斯拉在中国将新款 Model 3 价格下调 4%，而挪威销量激增 38%</li>
</ul>
</div><p>Disclaimer &amp; DisclosureReport an Issue</p>
<div class="lb-trans"><p>免责声明与披露报告问题</p>
</div>

Healius 董事增持股份，显示出对公司的信心